- Open Access
Spinal microglial motility is independent of neuronal activity and plasticity in adult mice
© Chen et al; licensee BioMed Central Ltd. 2010
Received: 29 January 2010
Accepted: 9 April 2010
Published: 9 April 2010
Microglia are the resident macrophages in the central nervous system. In the spinal cord dorsal horn, microglia stay in resting condition during physiological sensory processing, and are activated under pathological conditions such as peripheral nerve injury. In cases such as this, the nearby resting microglia increase their motility and accumulate at the site of injury. However, direct evidence to support that nerve activity can enhance the motility of microglia has not yet to be reported. In this study we investigated whether the activation of spinal microglia under in vivo nerve injury may be mimicked by neuronal activity in the spinal cord slice preparation. We found that local application of spinal excitatory neurotransmitters, such as glutamate and substance P did not cause any change in the motility of microglial cells in the spinal cord dorsal horn. The motility of microglial cells is unlikely modulated by other transmitters, neuromodulators and chemokines, because similar applications such as GABA, serotonin, noradrenaline, carbachol, fractalkine or interleukin did not produce any obvious effect. Furthermore, low or high frequency stimulation of spinal dorsal root fibers at noxious intensities failed to cause any enhanced extension or retraction of the microglia processes. By contrast, focal application of ATP triggered rapid and robust activation of microglial cells in the spinal dorsal horn. Our results provide the first evidence that the activation of microglia in the spinal cord after nerve injury is unlikely due solely to neuronal activity, non-neuronal factors are likely responsible for the activation of nerve injury-related microglial cells in the spinal dorsal horn.
Microglial cells are the principal immune-response cells in the central nervous system (CNS) [1, 2]. In physiological conditions, they are found in a "resting" state - typically exhibiting ramified processes with high motility . Under pathological conditions, these cells are transformed from the resting condition to an activated condition, exhibiting phagocytoxic, chemotaxis and secretory reactions [4–6]. A growing body of literature indicates that spinal microglia can be activated after nerve injury [4, 5], suggesting the possibility that neuronal activity may contribute to microglia activation. This possibility is further supported by studies showing that several neurotransmitter receptors can be expressed on cultured microglia cells, including NMDA, GABA, opioid and adrenergic receptors [7–11]. However, in a recent study using the brain slice preparation for adult mice, we found that microglia did not respond to either a glutamate or GABA application, or activity-dependent long-term potentiation (LTP) . In addition to these findings, we found that nerve injury did not cause any activation of microglial cells in supraspinal central nuclei such as the anterior cingulate cortex (ACC) where excitatory synaptic transmission was significantly enhanced after nerve injury . In support of previous reports in the spinal cord, we also found that microglial cells were activated in spinal cord dorsal horn after the nerve injury . One possible explanation is that spinal microglia may be more sensitive to abnormal neuronal activity than those in higher brain regions.
The spinal cord dorsal horn is a key area for nociceptive transmission and modulation . In the spinal cord, LTP is proposed to be the key cellular mechanism for pathological pain [14, 15]. Noxious stimuli of sciatic nerve or hindpaw can induce LTP in spinal dorsal horn neurons [15, 16]. Although microglia in the spinal cord is believed to play an important role in neuropathic pain [4, 13, 17], it is still unclear if LTP inducing protocols activates spinal microglia. To test this possibility, we investigated the motility of microglia in the dorsal horn of spinal cord slices of transgenic mice with green fluorescent protein (GFP) exclusively expressed in microglia [12, 18]. Chemicals known to mimic or enhance neuronal activity were applied locally. Electrical stimulation of the dorsal root fibers that has been known to induce spinal LTP was also tested. We found that the activation of the spinal microglia is independent of synaptic or neuronal activity, and the activation after nerve injury is unlikely driven by nerve activity in an activity-dependent manner.
To investigate the microglial cells in spinal cord dorsal horn, we used transgenic mice with GFP-labeled microglia cells as previously reported [12, 18–20]. Similar to microglial cells in supraspinal structures in vivo and in vitro [12, 13, 20], most of the microglia cells in the spinal cord slices showed ramified with active moving processes, while hypertrophied, monopolarized, bipolarized and amoeboid cells were also observed. These results suggest that the status of microglia in in vitro spinal cord slices is similar to those in spinal dorsal horn in vivo. Under the confocal microscope, the processes of ramified microglia in brain slices were very dynamic, showing rapid extensions and retractions with a speed of 1 μm/min.
Effect of excitatory neurotransmitters on the motility of microglia in spinal dorsal horn
We also applied AMPA and NMDA at different doses (1 or 10 mM) to examine if microglial cells may be activated. Similar to the results of glutamate, neither AMPA nor NMDA application affect the status of microglial cells in the spinal cord dorsal horn (n = 4 slices/4 mice in each group; Fig. 1, Fig 2B-C). To examine if the enhancement of local glutamate by inhibiting glutamate uptake may affect microglia, we also applied the selective glutamate uptake inhibitor dihydrokainate (DHK) at 1 or 10 mM. We found that DHK did not cause any obvious effect (n = 4 slices/3 mice; Fig 1, Fig 2D). In addition to glutamate, Substance P (SP) is a neuropeptide that contributes to nociceptive sensory transmission in the spinal cord . To test if SP may trigger any activation of microglia, we performed local application of SP at two different doses (1 or 10 mM). Similarly, SP did not induce any obvious enhancement in the motility of microglia (n = 5 slices/5 mice in each group; Fig. 1, Fig 2E).
Effect of inhibitory neurotransmitters on the motility of microglia in spinal dorsal horn
Effects of neuromodulators on the motility of microglia in spinal dorsal horn
Spinal nociceptive transmission is regulated by multiple neurotransmitters released locally or from descending projection fibers, including serotonin (5-HT), noradrenalin (NA), acetylcholine and opioid peptide [23–27]. Because neither excitatory transmitter glutamate nor inhibitory neurotransmitter GABA/glycine enhance the motility of microglia, we decided to examine whether neuromodulators have affect on the motility of microglia. Agonists that activate the neuromodulators' receptors, including 5-HT, NA, carbachol and morphine, were applied at two different doses (1 or 10 mM). After application of 1 mM 5-HT (n = 4 slices/4 mice), NA (n = 5 slices/4 mice), carbachol (n = 5 slices/4 mice) or morphine (n = 6 slices/5 mice), however, no significant enhancement of the motility of microglia was observed (Figs. 3C-F). The ratios of extended/retracted processes or distances of microglia were summarized in Fig. 1. The ratios of extended/retracted processes or distances after 10 mM drug application were similar to those after drug application (p > 0.05).
The effect of the stimulation of dorsal root on the motility of microglia
Number of microglia cells in layer I-V of spinal dorsal horn after low frequency dorsal root stimuli (n = 6)
Ipsilateral (number/mm2, Mean ± SEM)
Contralateral (number/mm2, Mean ± SEM)
314.5 ± 19.4
301.5 ± 12.8
289.7 ± 15.3
273.1 ± 16.4
212.1 ± 22.3
226.2 ± 17.8
180.5 ± 10.8
165.4 ± 17.2
182.3 ± 16.7
183.8 ± 14.3
Number of microglia cells in layer I-V of spinal dorsal horn after high frequency dorsal root stimuli (n = 6)
Ipsilateral (number/mm2, Mean ± SEM)
Contralateral (number/mm2, Mean ± SEM)
331.5 ± 22.3
311.1 ± 16.7
290.7 ± 18.4
293.9 ± 17.7
224.3 ± 23.9
242.0 ± 18.8
197.1 ± 18.2
177.0 ± 16.3
190.8 ± 14.5
182.7 ± 10.9
Effect of chemokines on the motility of microglia in spinal dorsal horn
In spinal cord dorsal horn, activated microglia can release some chemokines like NGF, BDNF, IL-1β, IL-6 and TNF-α. These factors may spread and activate adjacent microglia and neurons [4, 5, 17, 33]. To test the possible effects on spinal microglia, we applied them (10 or 100 ng/ml) to the microglia cells in spinal cord slice preparation. Application of NGF (n = 4 slices/3 mice), BDNF (n = 5 slices/4 mice), IL-1β (n = 6 slices/6 mice), IL-6 (n = 5 slices/4 mice) or TNF-α (n = 6 slices/5 mice) did not enhance the motility of the microglia (Figs. 6C-G). The ratios of extended/retracted processes or distances of microglia after application of 10 ng/ml NGF, BDNF, IL-1β, IL-6 or TNF-α were summarized in Fig. 1.
Effect of ATP on the motility of microglia in spinal dorsal horn
In this study, by combining a time lapse confocal imaging and histological observation, we demonstrated that motility of microglia in the spinal dorsal horn is not driven by neuronal activity directly. Stimulation of sensory afferent fibers at noxious intensities did not cause any activation of microglial cells. Furthermore, stimulation protocols that are known to induce long-term plasticity in spinal cord dorsal horn neurons failed to trigger any alteration in microglia. These results are important as they provide the first evidence that spinal microglia are not likely regulated by sensory inputs under physiological or pathological conditions. Although recent studies confirmed the activation of spinal microglia by nerve injury using the same transgenic mice , we suggest that activation of microglia in animal models for neuropathic pain is likely caused by non-neuronal factors after nerve injury. However, we cannot rule out the possibility that the microchemical environment within spinal microglial cells may change and release chemical, diffusible molecules.
In physiological conditions, the majority of microglia are found to be in a resting state. They have ramified processes with continuous extending and retracting reaction for detecting changes [3, 19]. Our previous work of cortical and hippocampal slices confirm the existence of similar resting microglial cells within the central nervous system. In animal models of neuropathic pain in rats and mice, activation of microglia were consistently observed as discussed in our recent paper. One major hypothesis is that the activation of microglia by nerve injury is caused by abnormal sensory input activity. However, in the present study, we found that microglial cells were not activated by nerve activity or application of different chemicals that mimic sensory transmission and modulation. One possible explanation for this failure to activate is the use of in vitro slice preparation. Our recent studies however favor the use of brain/spinal slice preparation for the investigation of microglia [12, 20, 34]. In all slice preparations including the present study, we found that the basal microglia are similar to in vivo resting microglia in the same brain region, and application of ATP but not Glu and GABA can enhance the motility of microglia [12, 20].
Despite the expression of AMPA, NMDA, GABA, opioid and adrenergic receptors on cultured microglia [7–11], the present study showed no effect of different receptor agonists on the resting microglia in acute spinal cord slices. We propose that microglia in CNS may not be 'simply' activated by neuronal activity or LTP/LTD like plasticity.
Chemokines are one kind of signal involved with microglia activation. Among them, MCP-1 and FKN are considered as neuronal-microglia signals. They are reported to be expressed on DRG neurons and spinal dorsal horn neurons after nerve injury [35–39]. MCP-1 and FKN can combine to their receptors [4, 31, 32] expressed on microglia and induce their activation. Consequently, activated microglia release chemokines like BDNF, NGF, IL-1β, IL-6 and TNF-α, which act on resident microglia and neurons and result in continuous tissue sensitization and exaggerated pain [6, 40–42]. In this study, we didn't find any enhanced motility of microglia after local application of MCP-1, FKN, BDNF, NGF, IL-1β, IL-6 and TNF-α, indicating that a single chemokine is not powerful enough to enhance the motility of microglia in spinal cord slices.
In the present study, ATP application but not dorsal root stimulation can cause increased motility of microglia. This finding confirms that microglial cells in spinal cord slice preparation are similar to those in vivo in term of ATP sensitivity. Considering ATP can be released from efferent terminals after dorsal root stimulation , we think that removing the possible inhibitory elements in the circumstance context in pathological condition may be important for the activation of microglia. In normal condition, dorsal root stimulation induced synaptic release of ATP may be rapidly degradation by ATP-hydrolyzing enzyme in situ and cannot reach a high degree to increase the motility of microglia .
Although no enhanced motility of microglia was observed, it does not exclude the possibility that biochemical changes may happen after drug application or LTP induction within microglial cells. After peripheral nerve injury, the first changes in spinal microglia are the withdrawal processes and enlarged soma , which is similar to the "rundown" phenomenon observed in our study and reflects a gradual activation of microglia. Since the increased number of microglia in spinal cord only reach the peak 2-3 days after nerve injury, the neuronal activity and LTP induction induced activation of microglia may be a slowly procedure [5, 13]. In current study, thirty minutes observation may be not long enough for detecting possible chronic activation of microglia, long-term observations under in vivo conditions should be carried out in the future to study if microglia in spinal cord can be activated after dorsal root stimulation.
In summary, our work on the spinal cord dorsal horn indicates that the motility of spinal microglia cannot be enhanced by dorsal root stimuli or local application of neurotransmitters, neuromodulators and chemokines, which is consistent with our previous works on brain slices. These results suggest that resting microglia in the CNS may not be directly related to synaptic transmission and plasticity. Activation of microglia in a cultured dish or in vivo may be due to the combined effects of the co-release of several signals and removal of inhibitory factors.
Heterozygous Cx3cr1GFP/+ mice were used for all the experiments . All mice were maintained on a 12-h light/dark cycle with food and water provided ad libitum. All protocols used were approved by The Animal Care and Use Committee at the University of Toronto.
Acute spinal cord slice preparation
Adult male or female mice (6-10 wks old) were anesthetized with 1-2% urethan, and body temperature was kept in the range 35-37°C with an infrared lamp. A lumbosacral laminectomy was performed and a 1-2.0 cm length of spinal cord with attached dorsal roots was excised. The spinal cord was placed in cold (0-4°C) oxygenated (95% O2-5% CO2) artificial cerebrospinal fluid (ACSF) solution containing (in mM) 124 NaCl, 25 NaHCO3, 2.5 KCl, 1 KH2PO4, 2 CaCl2, 2 MgSO4, and 10 glucose. After removal of the dura mater, all ventral and dorsal roots, with the exception of the L3 or L4 dorsal root on one side, were cut near the root entry zone. The pia-arachnoid membrane was then removed, sparing the area around the site of insertion of the preserved dorsal root. The spinal cord, together with the attached dorsal root, was placed in a shallow groove formed in an agar block. The spinal cord was immersed in cold ACSF solution and a transverse slice (500-700 μm) with attached dorsal root was cut with a Vibratome according to the protocols reported before [43, 44]. The slice was then completely submerged and superfused continuously with ACSF solution equilibrated with 95% O2, 5% CO2 at room temperature for 1 hour and then transferred to a recording chamber and perfused with oxygenated ACSF solution at 3-4 ml/min at 34 ± 1°C. The dorsal root of the spinal cord slice was then sucked into a suction electrode for electronic stimuli.
Spinal cord slices without dorsal root were also prepared for local drug microinjection. All the procedures for making slices are the same to those mentioned above except that all the dorsal roots and pia-arachnoid were thoroughly removed from the surface of the spinal cord and spinal cord slices without dorsal roots were cut. Local drug application and LTP induction were carried out in slices within 3 hrs after cutting operation for observing the motility of ramified microglia and in slices more than 3 hrs to observe the motility of ameboid microglia cells.
GFP-labeled microglia in dorsal horn of the spinal cord (layers I-V) were imaged by confocal microscope (Fluoview FV 1000, Olympus, Tokyo, Japan). The laser with a wavelength of 488 nm was used for GFP excitation, and 633 nm was used for DIC images. The image of microglia was collected for 8-10 consecutive focal steps of 2 μm once every 2 min using × 40, 0.8 numeric aperture water-immersion objectives. XYZT image galleries were collected, and Z projections were made for the quantification.
Local Drug microinjection procedures
All drugs were obtained from Sigma (St. Louis, MO, USA) except monocyte chemoattractant protein-1 (MCP-1), fractalkine (FKN), nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), interleukin (IL)-1β, IL-6 and tumor necrosis factor (TNF)-α (Peprotech, Embrun, Canada). A picopump (pneumatic picopump, WPI, Sarasota, FL) was used to apply neurotransmitters, neuromodulators and cytokines to induce microglial chemotaxis according to our previous reports . The diameter of the drug application pipette tip was 3-4 μm. The pressure and duration of the puff was 5 psi and 100 ms, respectively.
Recording and stimulation
To study the effect of electronic stimuli on microglial motilities, the 40 volt, 0.5 ms low frequency (LFS, 2 Hz, 2-3 min) or high frequency (HFS, 100 Hz, given in 5 trains of 1 s duration at 10 s intervals) electronic stimuli, which were proved to induce LTP effect in different groups of spinal dorsal horn neurons, were delivered through the electrode [15, 28, 29]. To make sure that the stimuli could be carried out properly, a field recording electrode was used for field excitatory postsynaptic potential (EPSP) recording. The recording electrode was filled with ACSF and inserted into ipsilateral part of the layer V-VI, 200-300 μm far away from the confocal imaging area. The field EPSP data was amplified and filtered by Axopatch 200B amplifier, digitalized by Digidata 1322A and analyzed by pClamp 8.0 software (Molecular Devices, Union City, CA).
After the procedure for dorsal root stimuli and confocal imaging, spinal cord slices with dorsal root would be kept staying in ACSF for one hour and then removed to fixation solution containing 4% paraformaldehyde in 0.01 M phosphate buffered saline (PBS, pH 7.4) for 24 hrs. Subsequently, the spinal cords were placed into 30% (w/v) sucrose in 0.01 M PBS overnight at 4-8°C. After making a pinhole in the ventral part of the sample contralateral to the dorsal root, the fixed spinal cord was cut serially into 30 μm-thick frontal sections on a freezing microtome (Kryostat 1720; Leitz, Mannheim, Germany). Then the serial sections were mounted onto glass slides, air dried, cover-slipped with a mixture of 50% (v/v) glycerin and 2.5% (w/v) triethylene diamine in 0.01 M PBS, and observed with the confocal microscope (FV 1000; Olympus).
The microglial motilities were analyzed by using Image-Pro Plus software (IPP 5.0., Media cybernetics, Silver Spring, USA). The number, distance, and volume of extending and retracting microglial processes were calculated every 2 min. Microglia quantification was performed on sections of 30 μm thickness. Only the cell bodies were taken into account. Cell counting was performed by using confocal microscope under 20× objective through IPP 5.0 software. Layers I-V in ipsilateral and controlateral sites of dorsal root were examined for each of the three randomly selected sections per mouse. Data were expressed as mean ± SEM. Statistical comparisons were performed with the Student's t-test. In all cases, P < 0.05 was considered statistically significant.
This work was supported by Grants from the EJLB-CIHR Michael Smith Chair in Neurosciences and Mental Health, Canada Research Chair, NeuroCanada, and CIHR operating grants (CIHR66975 and CIHR84256) (M. Z.). M.Z. is also supported by the World-Class University (WCU) program of the Ministry of Education, Science and Technology in Korea through KOSEF (R32-10142). We thank Drs. Wen-Biao Gan and Dan R. Littman for kindly providing us with Cx3cr1GFP/GFP mice.
- Hickey WF: Basic principles of immunological surveillance of the normal central nervous system. Glia 2001, 36: 118–124. 10.1002/glia.1101PubMedView ArticleGoogle Scholar
- Streit WJ, Mrak RE, Griffin WS: Microglia and neuroinflammation: a pathological perspective. J Neuroinflammation 2004, 1: 14. 10.1186/1742-2094-1-14PubMed CentralPubMedView ArticleGoogle Scholar
- Nimmerjahn A, Kirchhoff F, Helmchen F: Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 2005, 308: 1314–1318. 10.1126/science.1110647PubMedView ArticleGoogle Scholar
- Inoue K, Tsuda M: Microglia and neuropathic pain. Glia 2009, 57: 1469–1479. 10.1002/glia.20871PubMedView ArticleGoogle Scholar
- Tsuda M, Inoue K, Salter MW: Neuropathic pain and spinal microglia: a big problem from molecules in "small" glia. Trends Neurosci 2005, 28: 101–107. 10.1016/j.tins.2004.12.002PubMedView ArticleGoogle Scholar
- McMahon SB, Malcangio M: Current challenges in glia-pain biology. Neuron 2009, 64: 46–54. 10.1016/j.neuron.2009.09.033PubMedView ArticleGoogle Scholar
- Turchan-Cholewo J, Dimayuga FO, Ding Q, Keller JN, Hauser KF, Knapp PE, Bruce-Keller AJ: Cell-specific actions of HIV-Tat and morphine on opioid receptor expression in glia. J Neurosci Res 2008, 86: 2100–2110. 10.1002/jnr.21653PubMed CentralPubMedView ArticleGoogle Scholar
- Farber K, Kettenmann H: Physiology of microglial cells. Brain Res Brain Res Rev 2005, 48: 133–143. 10.1016/j.brainresrev.2004.12.003PubMedView ArticleGoogle Scholar
- Fields RD, Burnstock G: Purinergic signalling in neuron-glia interactions. Nat Rev Neurosci 2006, 7: 423–436. 10.1038/nrn1928PubMed CentralPubMedView ArticleGoogle Scholar
- Calvo CF, Cesselin F, Gelman M, Glowinski J: Identification of an opioid peptide secreted by rat embryonic mixed brain cells as a promoter of macrophage migration. Eur J Neurosci 2000, 12: 2676–2684. 10.1046/j.1460-9568.2000.00145.xPubMedView ArticleGoogle Scholar
- Liu GJ, Nagarajah R, Banati RB, Bennett MR: Glutamate induces directed chemotaxis of microglia. Eur J Neurosci 2009, 29: 1108–1118. 10.1111/j.1460-9568.2009.06659.xPubMedView ArticleGoogle Scholar
- Wu LJ, Zhuo M: Resting microglial motility is independent of synaptic plasticity in mammalian brain. J Neurophysiol 2008, 99: 2026–2032. 10.1152/jn.01210.2007PubMedView ArticleGoogle Scholar
- Zhang F, Vadakkan KI, Kim SS, Wu LJ, Shang Y, Zhuo M: Selective activation of microglia in spinal cord but not higher cortical regions following nerve injury in adult mouse. Mol Pain 2008, 4: 15. 10.1186/1744-8069-4-15PubMed CentralPubMedView ArticleGoogle Scholar
- Zhuo M: Neuronal mechanism for neuropathic pain. Mol Pain 2007, 3: 14. 10.1186/1744-8069-3-14PubMed CentralPubMedView ArticleGoogle Scholar
- Sandkuhler J: Understanding LTP in pain pathways. Mol Pain 2007, 3: 9. 10.1186/1744-8069-3-9PubMed CentralPubMedView ArticleGoogle Scholar
- Sandkuhler J, Liu X: Induction of long-term potentiation at spinal synapses by noxious stimulation or nerve injury. Eur J Neurosci 1998, 10: 2476–2480. 10.1046/j.1460-9568.1998.00278.xPubMedView ArticleGoogle Scholar
- Ji RR, Suter MR: p38 MAPK, microglial signaling, and neuropathic pain. Mol Pain 2007, 3: 33. 10.1186/1744-8069-3-33PubMed CentralPubMedView ArticleGoogle Scholar
- Jung S, Aliberti J, Graemmel P, Sunshine MJ, Kreutzberg GW, Sher A, Littman DR: Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertion. Mol Cell Biol 2000, 20: 4106–4114. 10.1128/MCB.20.11.4106-4114.2000PubMed CentralPubMedView ArticleGoogle Scholar
- Davalos D, Grutzendler J, Yang G, Kim JV, Zuo Y, Jung S, Littman DR, Dustin ML, Gan WB: ATP mediates rapid microglial response to local brain injury in vivo. Nat Neurosci 2005, 8: 752–758. 10.1038/nn1472PubMedView ArticleGoogle Scholar
- Wu LJ, Vadakkan KI, Zhuo M: ATP-induced chemotaxis of microglial processes requires P2Y receptor-activated initiation of outward potassium currents. Glia 2007, 55: 810–821. 10.1002/glia.20500PubMedView ArticleGoogle Scholar
- Li P, Wilding TJ, Kim SJ, Calejesan AA, Huettner JE, Zhuo M: Kainate-receptor-mediated sensory synaptic transmission in mammalian spinal cord. Nature 1999, 397: 161–164. 10.1038/16469PubMedView ArticleGoogle Scholar
- Li P, Zhuo M: Substance P and neurokinin A mediate sensory synaptic transmission in young rat dorsal horn neurons. Brain Res Bull 2001, 55: 521–531. 10.1016/S0361-9230(01)00553-6PubMedView ArticleGoogle Scholar
- Feng YP, Li YQ, Wang W, Wu SX, Chen T, Shigemoto R, Mizuno N: Morphological evidence for GABA/glycine-cocontaining terminals in synaptic contact with neurokinin-1 receptor-expressing neurons in the sacral dorsal commissural nucleus of the rat. Neurosci Lett 2005, 388: 144–148. 10.1016/j.neulet.2005.06.022PubMedView ArticleGoogle Scholar
- Sawynok J, Reid A: Interactions of descending serotonergic systems with other neurotransmitters in the modulation of nociception. Behav Brain Res 1996, 73: 63–68. 10.1016/0166-4328(96)00072-1PubMedView ArticleGoogle Scholar
- Watkins LR, Hutchinson MR, Johnston IN, Maier SF: Glia: novel counter-regulators of opioid analgesia. Trends Neurosci 2005, 28: 661–669.PubMedView ArticleGoogle Scholar
- Lograsso M, Nadeson R, Goodchild CS: The spinal antinociceptive effects of cholinergic drugs in rats: receptor subtype specificity in different nociceptive tests. BMC Pharmacol 2002, 2: 20. 10.1186/1471-2210-2-20PubMed CentralPubMedView ArticleGoogle Scholar
- Millan MJ: Descending control of pain. Prog Neurobiol 2002, 66: 355–474. 10.1016/S0301-0082(02)00009-6PubMedView ArticleGoogle Scholar
- Ikeda H, Heinke B, Ruscheweyh R, Sandkuhler J: Synaptic plasticity in spinal lamina I projection neurons that mediate hyperalgesia. Science 2003, 299: 1237–1240. 10.1126/science.1080659PubMedView ArticleGoogle Scholar
- Ikeda H, Stark J, Fischer H, Wagner M, Drdla R, Jager T, Sandkuhler J: Synaptic amplifier of inflammatory pain in the spinal dorsal horn. Science 2006, 312: 1659–1662. 10.1126/science.1127233PubMedView ArticleGoogle Scholar
- Watkins LR, Milligan ED, Maier SF: Spinal cord glia: new players in pain. Pain 2001, 93: 201–205. 10.1016/S0304-3959(01)00359-1PubMedView ArticleGoogle Scholar
- Abbadie C, Lindia JA, Cumiskey AM, Peterson LB, Mudgett JS, Bayne EK, DeMartino JA, MacIntyre DE, Forrest MJ: Impaired neuropathic pain responses in mice lacking the chemokine receptor CCR2. Proc Natl Acad Sci USA 2003, 100: 7947–7952. 10.1073/pnas.1331358100PubMed CentralPubMedView ArticleGoogle Scholar
- Lindia JA, McGowan E, Jochnowitz N, Abbadie C: Induction of CX3CL1 expression in astrocytes and CX3CR1 in microglia in the spinal cord of a rat model of neuropathic pain. J Pain 2005, 6: 434–438. 10.1016/j.jpain.2005.02.001PubMedView ArticleGoogle Scholar
- Tsuda M, Shigemoto-Mogami Y, Koizumi S, Mizokoshi A, Kohsaka S, Salter MW, Inoue K: P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury. Nature 2003, 424: 778–783. 10.1038/nature01786PubMedView ArticleGoogle Scholar
- Boucsein C, Zacharias R, Farber K, Pavlovic S, Hanisch UK, Kettenmann H: Purinergic receptors on microglial cells: functional expression in acute brain slices and modulation of microglial activation in vitro. Eur J Neurosci 2003, 17: 2267–2276. 10.1046/j.1460-9568.2003.02663.xPubMedView ArticleGoogle Scholar
- Thacker MA, Clark AK, Bishop T, Grist J, Yip PK, Moon LD, Thompson SW, Marchand F, McMahon SB: CCL2 is a key mediator of microglia activation in neuropathic pain states. Eur J Pain 2009, 13: 263–272. 10.1016/j.ejpain.2008.04.017PubMedView ArticleGoogle Scholar
- White FA, Sun J, Waters SM, Ma C, Ren D, Ripsch M, Steflik J, Cortright DN, Lamotte RH, Miller RJ: Excitatory monocyte chemoattractant protein-1 signaling is up-regulated in sensory neurons after chronic compression of the dorsal root ganglion. Proc Natl Acad Sci USA 2005, 102: 14092–14097. 10.1073/pnas.0503496102PubMed CentralPubMedView ArticleGoogle Scholar
- Harrison JK, Jiang Y, Chen S, Xia Y, Maciejewski D, McNamara RK, Streit WJ, Salafranca MN, Adhikari S, Thompson DA, et al.: Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia. Proc Natl Acad Sci USA 1998, 95: 10896–10901. 10.1073/pnas.95.18.10896PubMed CentralPubMedView ArticleGoogle Scholar
- Nishiyori A, Minami M, Ohtani Y, Takami S, Yamamoto J, Kawaguchi N, Kume T, Akaike A, Satoh M: Localization of fractalkine and CX3CR1 mRNAs in rat brain: does fractalkine play a role in signaling from neuron to microglia? FEBS Lett 1998, 429: 167–172. 10.1016/S0014-5793(98)00583-3PubMedView ArticleGoogle Scholar
- Verge GM, Milligan ED, Maier SF, Watkins LR, Naeve GS, Foster AC: Fractalkine (CX3CL1) and fractalkine receptor (CX3CR1) distribution in spinal cord and dorsal root ganglia under basal and neuropathic pain conditions. Eur J Neurosci 2004, 20: 1150–1160. 10.1111/j.1460-9568.2004.03593.xPubMedView ArticleGoogle Scholar
- Coull JA, Beggs S, Boudreau D, Boivin D, Tsuda M, Inoue K, Gravel C, Salter MW, De Koninck Y: BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain. Nature 2005, 438: 1017–1021. 10.1038/nature04223PubMedView ArticleGoogle Scholar
- Milligan ED, Watkins LR: Pathological and protective roles of glia in chronic pain. Nat Rev Neurosci 2009, 10: 23–36. 10.1038/nrn2533PubMed CentralPubMedView ArticleGoogle Scholar
- Ozaktay AC, Kallakuri S, Takebayashi T, Cavanaugh JM, Asik I, DeLeo JA, Weinstein JN: Effects of interleukin-1 beta, interleukin-6, and tumor necrosis factor on sensitivity of dorsal root ganglion and peripheral receptive fields in rats. Eur Spine J 2006, 15: 1529–1537. 10.1007/s00586-005-0058-8PubMedView ArticleGoogle Scholar
- Yoshimura M, Jessell TM: Primary afferent-evoked synaptic responses and slow potential generation in rat substantia gelatinosa neurons in vitro. J Neurophysiol 1989, 62: 96–108.PubMedGoogle Scholar
- Yasaka T, Kato G, Furue H, Rashid MH, Sonohata M, Tamae A, Murata Y, Masuko S, Yoshimura M: Cell-type-specific excitatory and inhibitory circuits involving primary afferents in the substantia gelatinosa of the rat spinal dorsal horn in vitro. J Physiol 2007, 581: 603–618. 10.1113/jphysiol.2006.123919PubMed CentralPubMedView ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.